
Solving Antimicrobial Resistance, Vaccines, Antibiotics | Immunethep đ”đč | E55 [Sponsored]
Antibiotic-resistant superbugs could become a greater threat than cancer. Bruno and Pedro at the startup Immunethep explain how theyâre tackling the crisis with vaccines.
We discuss how Immunethep could challenge Pfizerâs $7bn+ Prevnar, and how one pharma company got on board after a representative said he doesnât believe in vaccines!
---
For transparency, this episode has been sponsored by Immunethep. Learn more at https://bit.ly/flot-immunethep
---
âïž ABOUT THE SPEAKERS
Bruno is Immunethepâs co-founder and CEO, and co-founder of the startup creator Venture Catalysts. He also co-founded the tech startup Abyssal, which was acquired by marine robotics company Ocean Infinity in 2021.
Co-founder and CSO Pedro is a biomedical scientist previously serving as an Assistant Researcher at i3S. He has a PhD in Biomedical Sciences from the University of Porto and boasts over 30 peer-reviewed publications.
đ LINKS MENTIONED
- Immunethep website â https://www.immunethep.com/
- When Cancer is no longer the biggest threat: AMRâs growing shadow over oncology â https://www.incate.net/when-cancer-is-no-longer-the-biggest-threat-amrs-growing-shadow-over-oncology/
- Antimicrobial resistance WHO page â https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance
- Center for Global Development: The Economics of Antibiotic Resistance â https://www.cgdev.org/sites/default/files/economics-antibiotic-resistance.pdf
- GSK completes Affinivax acquisition â https://www.gsk.com/en-gb/media/press-releases/gsk-completes-acquisition-of-affinivax-inc/
- AntĂłnio Portela, BIAL đ”đč | Parkinsonâs, Family-Owned Biotech | E54 âhttps://flot.bio/episode/antonio-portela-bial-parkinsons-biopharma/
đ TRANSCRIPT
Read the full transcript here: https://flot.bio/episode/immunethep-antimicrobial-resistance/
đ SHORT BLOGS BASED ON THIS EPISODE:
- Why Antimicrobial Resistance Is Bigger Than Cancer: https://flot.bio/antimicrobial-resistance-immunethep/
đžÂ DONATE
We welcome donations from individuals and businesses to support our podcast and allow us to create even more content: https://www.paypal.me/PhilipHemme
âïž SPONSORSHIP
Ready to amplify your brand to influential leaders in biotech and biopharma? Contact [email protected] and unlock sponsorship opportunities in our podcasts!
đ«¶ FOLLOW US
- Newsletter: http://eepurl.com/h_fnmH
- LinkedIn: https://www.linkedin.com/company/flot-bio/
- X (Twitter): https://x.com/FlotBio
đ LIKE/FOLLOW/REVIEW
Did you enjoy the episode? Please hit the like and subscribe button. Also, please let me know your thoughts in the comments below.
đïž ABOUT FLOT.BIO
Flot.bio is a show to watch the best Europeans in biotech to help you grow. Hosted by Philip Hemme. 25k monthly views. Free.
â° TIMESTAMPS
- [00:00:00] Intro
- [00:02:10] The overlooked antimicrobial resistance crisis
- [00:10:26] Immunethep: When Bruno Santos and Pedro Madureira teamed up
- [00:15:41] Taking down multiple superbugs with a single vaccine
- [00:27:30] Preparing to challenge Pfizerâs $7bn+ Prevnar
- [00:42:11] The Portuguese biotech ecosystem
- [00:46:10] Bruno Santosâ cross-disciplinary experience
- [00:48:09] Not taking ânoâ for an answer from big pharma
- [00:51:44] Immunethepâs IP and tech transfer achievements
- [00:55:44] Quick-fire questions
Flere episoder fra "Flot.bio x Philip Hemme"



GĂ„ ikke glip af nogen episoder af âFlot.bio x Philip Hemmeâ - abonnĂ©r pĂ„ podcasten med gratisapp GetPodcast.








